Welcome to the first blog post on Patient Engagement in Life Sciences. Over the next few posts we’ll focus on how Life Science organizations can run clinical trials that are more efficient and cost effective, while providing a better experience for the patient themselves, by engaging more deeply with the patient.
The early stages of this have become pretty common: text (SMS) messages sent to patients to remind them to take their medication, complete an eDiary (ePRO) or in some way take an action necessary for the trial. But what is just starting to develop is providing patients with more complex medical devices, ones that are usually reserved for the clinicians office, ones that – in this case – can even take the place of visits to the investigators / clinicians office.
A first iteration of this is a whitepaper published in 2011 Connected Devices that we entitled “Connected Devices in Clinical Trials). A good place to start, but needs some updating. And so over the next few blog posts, we’ll give you a more advanced view of this – including video on use of the devices.
But we’ll go further. As the whitepaper above attests, patient engagement can not only enhance clinical trials, but can also be used for a directly relationship between the patient and the pharma company for purposes of patient adherence, patient recruitment, or even other scenarios we haven’t thought of yet. We’ll explore those as well.
So – take a look at our earlier thinking – and check back next week at this time (Monday, 9am ET) for another view of Patient Engagement by Life Science companies.